The Psoriasis Association are pleased to announce their support for PsoProtect.
The Psoriasis Association are
pleased to announce their support for PsoProtect, an international
registry where health care professionals can report outcomes of
COVID-19 infection in people with psoriasis.
has been set up by
world-leading psoriasis researchers at Guy’s and St Thomas’ NHS
Foundation Trust, King’s College London, and the University of
Manchester to capture de-identified
information about the
outcomes and experiences of
individuals with psoriasis
who have had COVID-19.
provide real world information for clinicians to help them assess
risk in people with
psoriasis. The registry will
also help researchers to investigate whether
different medicines or co-morbidities of psoriasis affect the outcome
of COVID-19 infection.
registry will provide a vital clinical and research resource to
help in our collective fight against COVID-19 but please
note that the
registry is for clinicians to submit de-identified data, not
However, if you or a family member with psoriasis have had, or get
Coronavirus, please do ask your
to submit your data to PsoProtect.
will publish regular summaries and insights from the registry,
however, they are unable to provide
information on request. The latest data can be found here.
In October 2020, the first findings from PsoProtect were published. You can find out more here.
the most up-to-date advice on COVID-19 (Coronavirus), you should:
the guidance on the NHS
- Read the guidance on the Public Health England website